SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-006844
Filing Date
2021-01-12
Accepted
2021-01-12 09:10:28
Documents
3
Period of Report
2021-01-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d945260d8k.htm 8-K 18385
2 EX-99.1 d945260dex991.htm EX-99.1 18504
3 GRAPHIC g945260g0112120641856.jpg GRAPHIC 4103
  Complete submission text file 0001193125-21-006844.txt   43817
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 21522549
SIC: 2834 Pharmaceutical Preparations